This public procurement contract involves the ongoing supply of pharmaceutical products containing the active ingredient A10AE04 Insulin Glargine, specifically the brands Lantus and Toujeo, for a duration of 4 years. The contract is valued at approximately €10,586,321.88 and is intended for the Facu
Contract awarded. Originally published 9 months ago.
This public procurement contract involves the ongoing supply of medicinal products containing the active ingredient J01XX08 Linezolid infusion for a duration of 4 years. The contract is valued at approximately €1,822,211.52 and is intended for the health sector. The buyer is the Faculty Hospital of
This public procurement contract involves the supply of one research laptop and an AI module. The buyer is the Faculty Hospital of St. Anne in Brno, Czech Republic. The total value of the contract is 114,544. Suppliers interested in this opportunity can find more details at the provided link.
This public procurement contract involves the post-warranty repairs of medical devices and conducting safety and technical inspections, including checks of electrical equipment. Suppliers will be required to issue reports in accordance with the law 375/2022 Coll. on medical devices and in vitro diag
This public procurement contract involves the ongoing supply of diagnostic kits specifically designed for testing using the ELISA method. The contract will be established as a framework agreement for the supply of consumables with the winning bidder, lasting indefinitely. Suppliers are invited to pr
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
